Hospital
Peacehealth
Peacehealth was paid $30.72M by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is 99285, emergency room visit (most serious) — 50% of everything it billed.
33Billing provider infoPEACEHEALTH
SPRINGFIELD, OR 97477
SPRINGFIELD, OR 97477
33aNPI1083888515assigned 04/16/2008
33bProvider typeGeneral Acute Care Hospital
28Total paid$30.72M
24GClaims393,894
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oregon
Rank by total paid#3 of 17
Median peer was paid$13.35M
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SEIRER, JEFFREY controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,825 | $3.64M | |
| 2019 | 54,100 | $4.51M | |
| 2020 | 41,255 | $3.27M | |
| 2021 | 52,930 | $3.85M | |
| 2022 | 60,251 | $4.21M | |
| 2023 | 64,842 | $4.95M | |
| 2024incomplete | 72,691 | $6.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 50% | 42,274 | 37,011 | $15.42M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 27,806 | 25,009 | $7.20M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 17,687 | 16,337 | $3.30M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.3% | 12,229 | 10,803 | $1.33M |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 3.0% | 1,532 | 1,383 | $931K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.9% | 2,399 | 2,131 | $895K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.5% | 884 | 809 | $462K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,818 | 1,014 | $217K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,106 | 1,857 | $137K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,778 | 4,260 | $124K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,370 | 2,751 | $119K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,302 | 2,003 | $107K |
59 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,433 | $88K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 687 | $75K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 195 | $57K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 498 | $53K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,004 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 79,821 | $22K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 30 | $21K |
| 80053 | Comprehensive metabolic panel | <1% | 78,200 | $17K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 174 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 28,134 | $16K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 52 | $11K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 15 | $6K |
| 36415 | Collection of venous blood by venipuncture | <1% | 46,528 | $6K |
| G0378 | Hospital observation service, per hour | <1% | 434 | $6K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 40 | $6K |
| 84484 | <1% | 9,247 | $5K | |
| 81001 | <1% | 9,789 | $5K | |
| 84703 | <1% | 1,864 | $4K | |
| 86900 | <1% | 44 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 176 | $2K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 14 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 17 | $1K |
| 83690 | <1% | 5,235 | $1K | |
| 93017 | <1% | 20 | $1K | |
| G0398 | Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation | <1% | 12 | $946.56 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,453 | $684.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 297 | $527.00 |
| 93296 | <1% | 71 | $514.89 | |
| 87631 | <1% | 900 | $199.68 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 213 | $117.12 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 220 | $55.45 |
| 83735 | <1% | 750 | $9.38 | |
| A9270 | Non-covered item or service | <1% | 20 | $7.05 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 984 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 393 | $0.00 |
| 81003 | 0% | 25 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 29 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 13 | $0.00 |
| 85610 | 0% | 61 | $0.00 | |
| 80305 | 0% | 19 | $0.00 | |
| 81025 | 0% | 12 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 762 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 612 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 743 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 85 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 279 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 493 | $0.00 |
| 83880 | 0% | 30 | $0.00 | |
| 83605 | 0% | 172 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 22 | $0.00 |
| 85027 | 0% | 13 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 128 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 41 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 79 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 12 | $0.00 |
| 86901 | 0% | 44 | $0.00 | |
| 96376 | 0% | 14 | $0.00 | |
| 86850 | 0% | 44 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSEIRER, JEFFREY (SYS VP FIN INTEGRITY/CONTROLLER)
| Provider | Location | Paid |
|---|---|---|
| Peacehealth | Vancouver, WA | $81.65M |
| Peacehealth | Longview, WA | $48.29M |
| Peacehealth | Bellingham, WA | $47.27M |
| Peacehealth | Eugene, OR | $13.35M |
| Peacehealth | Vancouver, WA | $2.56M |
| Peacehealth | Eugene, OR | $1.84M |
| Peacehealth | Friday Harbor, WA | $1.06M |
| Peacehealth | Vancouver, WA | $1.00M |
| Peacehealth | Vancouver, WA | $814K |
| Peacehealth | Springfield, OR | $395K |
| Peacehealth | Bellingham, WA | $77K |
| Peacehealth | Kelso, WA | $13K |
| Peacehealth | Ketchikan, AK | $9K |
| Peacehealth | Eugene, OR | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.